Arbutus Biopharma Corporation
USD4.26
-0.22 (-4.91%)
CEO
Lindsay Androski
IPO Date
2007-07-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.44
Prev. Close
$4.48
Day Low
$4.19
Day High
$4.47
52W Low
$3.04
52W High
$5.10
Market Cap
$0.84B
Volume
1.74M
| 73,500 |
| $0.00 |
| 2 Feb 2026 | Androski Lindsay | director, officer: President and CEO | A-Award | Acquired | 71,700 | $4.39 |
| 2 Feb 2026 | Androski Lindsay | director, officer: President and CEO | A-Award | Acquired | 28,000 | $0.00 |
| 6 Aug 2025 | Sawhney Roger | director | A-Award | Acquired | 157,600 | $3.34 |
| 6 Aug 2025 | Sawhney Roger | director: | Disposed | 0 | $0.00 |
| 20 Mar 2025 | Beardsley Robert A | director | A-Award | Acquired | 157,600 | $3.20 |
| 6 Mar 2025 | Beardsley Robert A | director: | Disposed | 0 | $0.00 |
| 19 Feb 2025 | HASTINGS DAVID C | Chief Financial Officer | A-Award | Acquired | 365,800 | $3.29 |
| 19 Feb 2025 | HASTINGS DAVID C | Chief Financial Officer | A-Award | Acquired | 90,100 | $0.00 |